D.E. Shaw & Co’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.21M | Buy |
633,403
+572,497
| +940% | +$2.9M | ﹤0.01% | 1663 |
|
|
2025
Q1 | $322K | Buy |
+60,906
| New | +$322K | ﹤0.01% | 2628 |
|
|
2024
Q2 | – | Sell |
-61,963
| Closed | -$618K | – | 3434 |
|
|
2024
Q1 | $618K | Buy |
61,963
+46,904
| +311% | +$468K | ﹤0.01% | 2332 |
|
|
2023
Q4 | $148K | Sell |
15,059
-8,648
| -36% | -$85.3K | ﹤0.01% | 2727 |
|
|
2023
Q3 | $181K | Buy |
23,707
+11,862
| +100% | +$90.7K | ﹤0.01% | 2606 |
|
|
2023
Q2 | $88.5K | Sell |
11,845
-191,053
| -94% | -$1.43M | ﹤0.01% | 2704 |
|
|
2023
Q1 | $1.35M | Buy |
+202,898
| New | +$1.35M | ﹤0.01% | 2037 |
|